{{Rsnum
|rsid=6577
|Gene=GSTA2
|Chromosome=6
|position=52750617
|Orientation=minus
|GMAF=0.2383
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=GSTA2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 83.1 | 16.9 | 0.0
| HCB | 61.9 | 35.7 | 2.4
| JPT | 60.5 | 25.6 | 14.0
| YRI | 3.2 | 38.1 | 58.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 61.9 | 35.7 | 2.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19639209
|Title=The role of GSTA2 polymorphisms and haplotypes in breast cancer susceptibility: a case-control study in the Portuguese population
}}

{{PMID Auto
|PMID=17601350
|Title=A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.
|OA=1
}}

{{PMID Auto
|PMID=19859803
|Title=No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk.
}}

{{GET Evidence
|gene=GSTA2
|aa_change=Glu210Ala
|aa_change_short=E210A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6577
|overall_frequency_n=2658
|overall_frequency_d=10758
|overall_frequency=0.247072
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=35
|n_articles=0
|n_articles_annotated=0
|nblosum100=3
|autoscore=0
|webscore=N
}}

{{on chip | HumanOmni1Quad}}